Publication: AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems
Issued Date
2011-08-30
Resource Type
ISSN
1526632X
00283878
00283878
Other identifier(s)
2-s2.0-80055078651
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Neurology. Vol.77, No.9 (2011), 827-834
Suggested Citation
S. Siritho, I. Nakashima, T. Takahashi, K. Fujihara, N. Prayoonwiwat AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems. Neurology. Vol.77, No.9 (2011), 827-834. doi:10.1212/WNL.0b013e31822c61b1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/12373
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
AQP4 antibody-positive Thai cases: Clinical features and diagnostic problems
Other Contributor(s)
Abstract
Objective: To evaluate the prevalence of aquaporin-4 (AQP4) antibody in Thai patients with idiopathic inflammatory demyelinating CNS diseases (IIDCDs) and to analyze the significance of the autoantibody to distinguish neuromyelitis optica (NMO) and other NMO spectrum disorders (ONMOSDs) from other IIDCDs, especially multiple sclerosis (MS). Methods: We retrospectively evaluated 135 consecutive patients with IIDCDs seen at the MS clinic at Siriraj Hospital Bangkok Thailand, and classified them into NMO, ONMOSDs, optic-spinal MS (OSMS), classic MS (CMS), and clinically isolated syndrome (CIS) groups in this order with accepted diagnostic criteria. The patients' coded sera were tested separately for AQP4 antibody. Then the relations between the clinical diagnosis and the AQP4 antibody serologic status were analyzed. Results: Among the 135 patients, 53 (39.3%) were AQP4 antibody-positive. Although the AQP4 antibody-positive group had features of NMO, such as female predominance, long cord lesions ( > 3 vertebral bodies), and CSF pleocytosis, only 18 patients (33% of 54) fully met Wingerchuk 2006 criteria except for AQP4 antibody-seropositive status. We also detected some AQP4 antibody-positive patients in the OSMS (4 of 7), CMS (11 of 46), and CIS (1 of 16) groups. These patients had been misdiagnosed with MS because they often had brain lesions and never underwent spinal cord MRI examination or lacked long cord lesions. Conclusions: AQP4 antibody was highly prevalent (almost 40%) in Thai patients with IIDCDs. Moreover, only one-third of AQP4 antibody-positive patients fully met Wingerchuk 2006 criteria, and many were misdiagnosed with MS. A sensitive AQP4 antibody assay is required in this region because the therapy for NMO is different from that for MS. © 2011 by AAN Enterprises, Inc.